Inhibition of endothelial cell adhesion molecule expression improves colonic hyperalgaesia

Neurogastroenterology and Motility

Volumn 21, Issue 2, 2009, Pages 189-196

  Winchester, W J ^a   Johnson, A ^b   Hicks, G A ^a   Gebhart, G F ^c   Greenwood Van Meerveld, B ^b   McLean, P G ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Irritable bowel syndrome; Leukocyte adhesion; Visceral pain

Indexed keywords

CELL ADHESION MOLECULE; GI 270384; TRINITROBENZENESULFONIC ACID; ZYMOSAN;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON DILATATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HYPERALGESIA; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VISCERAL PAIN; WISTAR KYOTO RAT;

ANIMALS; CELL ADHESION; CELL ADHESION MOLECULES; COLITIS; COLON; DILATATION, PATHOLOGIC; E-SELECTIN; ENDOTHELIAL CELLS; GASTROINTESTINAL MOTILITY; HUMANS; HYPERALGESIA; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; POLYETHYLENE GLYCOLS; PURINES; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; TRINITROBENZENESULFONIC ACID; ZYMOSAN;

EID: 58849157973     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2008.01222.x     Document Type: Article

References (16)

1. Panes J., Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 1998 114 : 1066 90.
2. MacDonald JK, McDonald JW. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007 24 : CD006097.
3. Barish CF. Alicaforsen therapy in inflammatory bowel disease. Expert Opin Biol Ther 2005 5 : 1387 91.
4. Panes J, Perry M, Granger DN. Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br J Pharmacol 1999 126 : 537 50.
5. Panes J, Aceituno M, Gil F et al. Efficacy of an inhibitor of adhesion molecule expression (GI270384X) in the treatment of experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007 293 : G739 48.
6. Azpiroz F, Bouin M, Camilleri M et al. Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil 2007 19 : 62 88.
7. Bradesi S, McRoberts JA, Anton PA, Mayer EA. Inflammatory bowel disease and irritable bowel syndrome: separate or unified? Curr Opin Gastroenterol 2003 19 : 336 42.
8. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002 122 : 2032 48.
9. Jurgensen CH, Daluge SM, Selph JL et al. A novel orally-active inhibitor of ICAM-1 and E-selectin is efficacious in the treatment of colitis in Rhesus macaques. Gastroenterology 2000 118 : A863.
10. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res 1988 450 : 153 69.
11. Greenwood-Van Meerveld B, Venkova K, Hicks G, Dennis E, Crowell MD. Activation of peripheral 5-HT receptors attenuates colonic sensitivity to intraluminal distension. Neurogastroenterol Motil 2006 18 : 76 86.
12. Sengupta JN, Snider A, Su X, Gebhart GF. Effects of kappa opioids in the inflamed rat colon. Pain 1999 79 : 175 85.
13. Greenwood-Van Meerveld B, Johnson AC, Cochrane S, Schulkin J, Myers DA. Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats. Neurogastroenterol Motil 2005 17 : 415 22.
14. Fioramonti J, Gebhart GF. In vivo and transgenic animal models used to study visceral hypersensitivity. Neurogastroenterol Motil 2007 19 : 20 8.
15. Larauche MH, Bradesi S, Million M et al. Corticotropin releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats. Am J Physiol Gastrointest Liver Physiol 2008 294 : G1033 40.
16. Dunlop SP, Jenkins D, Neal KR et al. Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003 18 : 77 84.